Tag: Prescription Drugs
Elderly Who Start Thiopurine Tx for IBD Have Higher Risk for AEs
Advanced age, female gender are independent risk factors for adverse events
Uptitration of Drugs Varies With Target Dosage in Chronic HF
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Nintedanib Slows Fibrosing Interstitial Lung Disease
Nintedanib linked to lower rate of decline in forced vital capacity versus placebo in phase 3 trial
Heart Disease May Up Risk for Allopurinol-Linked Cutaneous AEs
Risk for hospital admission increased for allopurinol-associated severe cutaneous adverse reactions
Less Bleeding With Ticagrelor Alone in High-Risk Patients
Less bleeding with ticagrelor alone versus ticagrelor plus aspirin for patients after PCI
DPP4 Inhibitors Do Not Up Risk of Inflammatory Bowel Disease
Findings based on comparison to sulfonylureas, thiazolidinediones
Severe Adverse Cardiovascular Events Associated With Ibrutinib
Risk up for severe, sometimes fatal, events, including supraventricular arrhythmias, CNS events
Step-Up Strategy May Differ in Black Children With Asthma
Poorly controlled asthma in black children may respond to increased dose of inhaled glucocorticoid
Vedolizumab Beats Adalimumab for Ulcerative Colitis Remissions
But not for corticosteroid-free clinical remission; also, ustekinumab superior to placebo
More Blood Pressure Drugs Recalled
Some lots of losartan contaminated with the cancer-causing chemical N-methylnitrosobutyric acid
